Indianapolis, IN. – Several trends we’re following this year are focused around the patient’s voice and bringing it in early and often. Lilly recently released a new project; The Hero’s Journey Art Projectthat speaks to those trends and celebrates the hero’s that have participated in past clinical trials.
Conceived by Lilly’s Clinical Innovation team, clinical trial patients as well as members of the community are encouraged to express their thoughts through painting bricks that will be a part of several crowdsourced sculptures commissioned by artist, John Magnan.
“A clinical trail is its own hero’s journey. People give up something to possibly get something in return. They are coming to terms with changes in their own lives and have set out to find a new beginning.”
The project will consist of three sculptures that symbolize trail markers on the clinical trial journey and are named for each of the three phases: Departure, Initiation and Return.
The first installation was installed last March at the LiveStrong foundation in Austin, TX:
To learn more about this amazing project, visit www.herosjourneyart.com
Why This Matters:
As stated, our trends, Get Involved and Earlier Involvement both support the overall mission of the Hero’s Journey Art Project: the earlier and more involved patients are within the processes of healthcare, the better the outcomes and the end product is more likely to have higher utilization if the end user is involved the development.
To summarize these two trends:
Get Involved
The shift to outcomes-based metrics has finally put the spotlight on the member of the healthcare team most able to drive persistency and commitment: the patient. Providers are making significant investments in patient engagement and activation programs. They’re stratifying populations not just by health risk but by level of engagement. Research backs up those moves with proof that consistently shows that patients who are more involved in the self-management of their health are less likely to be hospitalized or to develop a chronic condition than those with lower engagement scores.
Earlier Involvement
Many pharmaceutical companies are giving patients a greater role in influencing development and commercialization strategies by creating models that examine every decision through the lens of the ultimate end user. Increasingly, that starts with bringing the patient voice into clinical trial design, thus ensuring that everything measured and evaluated aligns with what patients care about most. In 2017, that patient mindset will drive more and more pricing models, too. Brands will develop insights and communications connected to what patients find valuable and leverage those to proactively address challenges with coverage or market acceptance.
Download these trends as well as dozens more at inVentiv Health Trends Reports.
